SEC Form D · filed October 4, 2022
Vergent Bioscience, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (23)
Samuel D. Banks · MINNEAPOLIS, MNDirectorJohn Santini · MINNEAPOLIS, MNExec · DirectorJeffrey Julkowski · MINNEAPOLIS, MNDirector · PromoterRyan D. Egeland · MINNEAPOLIS, MNDirectorDouglas D. Kohrs · MINNEAPOLIS, MNDirectorJeffrey D. Yurecko · MINNEAPOLIS, MNExecRaymond D. Wong · MINNEAPOLIS, MNDirectorPatrick Arippol · Sao Paulo, GuernseyDirectorPeter W. Mooradian · Boston, MADirectorKyle Volluz · Dallas, TXExecPhilip H. Lukowski · CHICAGO, ILExec · DirectorJohn C. Hansen · Westlake Village, CADirectorDavid R. Schwartz · CHICAGO, ILDirector · PromoterElizabeth C. Fujino · Westlake Village, CADirectorMargo Shoup · MINNEAPOLIS, MNDirectorCurtis Floyd · BAKERSFIELD, CADirectorBruce Beretta · BAKERSFIELD, CADirectorKevin S. Little · Boca Raton, FLDirector · PromoterNEF Assignment Corporation · Chicago, ILExec · DirectorJason Castle · BAKERSFIELD, CADirectorParamijt Dosanjh · BAKERSFIELD, CAExecAlison Forsyth · Somerville, MADirectorMargo Shoup · MINNEAPOLIS, MNDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗